Recce Pharmaceuticals (RCE) Director Trades
Insider activity from ASX Appendix 3Y filings.
- Trades shown
- 10
- Bought (value)
- $14,318
- Sold (value)
- $7
- Net sentiment
- +$14,311
| Date | Director | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-08-06 | Unknown Director | Buy | — | — | — | View |
| 2026-07-31 | John Prendergast | Buy | 37,500 | — | — | View |
| 2026-02-24 | Unknown Director | Buy | — | — | — | View |
| 2026-02-22 | James Graham | Sell | 4,425,000 | — | — | View |
| 2025-10-14 | Unknown Director | Buy | — | — | — | View |
| 2025-10-07 | James Graham | Sell | 1,323,174 | — | $7 | View |
| 2025-05-16 | John Prendergast | Buy | 51,136 | $0.28 | $14,318 | View |
| 2025-05-16 | Unknown Director | Buy | — | — | — | View |
| 2024-11-21 | Unknown Director | Buy | — | — | — | View |
| 2024-11-14 | John Prendergast | Exercise | 5,650,000 | $0.1144 | $646,600 | View |
Source: ASX Appendix 3Y filings (Corporations Act s205G). Director trades must be lodged with the ASX within 14 days of the change in interest. See the official methodology.